cycl
signal
pathway
recycl
schemat
diagram
activ
deactiv
follow
ifng
stimul
follow
bind
cytokin
receptor
seri
tyrosin
phosphoryl
event
red
circl
occur
first
jak
autophosphoryl
transphosphoryl
phosphoryl
intracellular
part
receptor
creat
dock
site
recruit
also
phosphoryl
jak
lead
remov
receptor
dimer
transloc
nucleu
modul
target
gene
express
dephosphoryl
occur
nucleu
stat
export
back
cytoplasm
stephani
boissondupui
xiaofei
kong
satoshi
okada
sophi
cypowyj
ann
puel
laurent
abel
jeanlaur
casanova
genet
dissect
variou
human
infecti
diseas
led
definit
inborn
error
human
immun
four
type
includ
autosom
recess
ar
complet
defici
ii
ar
partial
defici
iii
autosom
domin
ad
defici
iv
ad
gain
activ
two
type
ar
defect
give
rise
broad
infecti
phenotyp
suscept
intramacrophag
bacteria
mostli
mycobacteria
virus
herp
virus
least
due
princip
impair
ifngmedi
ifnabmedi
immun
respect
clinic
outcom
depend
extent
defect
decreas
respons
cytokin
ad
defici
select
predispos
individu
mycobacteri
diseas
owe
impair
ifngmedi
immun
ifna
bmediat
immun
maintain
final
ad
gain
activ
associ
autoimmun
probabl
owe
enhanc
ifnabmedi
immun
surprisingli
also
associ
chronic
mucocutan
candidiasi
yet
undetermin
mechan
involv
inhibit
develop
cell
thu
germlin
mutat
human
defin
four
distinct
clinic
disord
variou
combin
viral
mycobacteri
fungal
infect
therefor
allel
human
locu
experi
natur
neatli
highlight
clinic
immunolog
impact
human
genet
dissect
infecti
phenotyp
introduct
structur
function
first
stat
identifi
key
transcript
factor
mediat
ifnab
signal
mice
human
gene
encod
two
isoform
gener
altern
splice
transcript
activ
encod
protein
amino
acid
kda
wherea
kda
act
dominantneg
inhibitor
lack
part
transactiv
domain
ser
phosphoryl
site
ser
hereaft
refer
involv
variou
signal
pathway
includ
ifnab
ifng
ifnl
egf
vegf
fgf
hgf
gh
angiotensin
osm
pathway
activ
conform
gener
pattern
stat
figur
briefli
bind
solubl
extracellular
agonist
specif
cell
surfac
receptor
lead
activ
specif
jak
constitut
associ
receptor
chain
jak
phosphoryl
intracellular
domain
receptor
therebi
creat
dock
site
latent
cytoplasm
recruit
undergo
tyr
phosphoryl
releas
receptor
complex
phosphoryl
form
homodim
heterodim
multim
transloc
nucleu
bind
conserv
genet
box
activ
modul
transcript
specif
target
gene
subsequ
dephosphoryl
nucleu
export
back
cytoplasm
remain
monom
antiparallel
unphosphoryl
dimer
role
unphosphoryl
mediat
transcript
activ
report
posttransl
modif
addit
phosphoryl
tyr
ser
residu
report
contribut
activ
protein
modif
includ
acetyl
methyl
sumoyl
howev
specif
role
posttransl
modif
tyr
ser
phosphoryl
remain
clarifi
ntermin
domain
ntd
known
involv
interact
protein
surfac
receptor
phosphoryl
nuclear
transloc
transcript
activ
facilit
tetramer
dephosphoryl
figur
iii
vi
iv
vii
v
viii
xviii
xvi
xv
xiv
xiii
xii
xi
x
ix
xxii
xxi
xx
xix
xviii
xxiii
xxiv
xxv
cooh
cc
dnab
l
ts
ta
py
ps
represent
human
gene
domain
correspond
protein
key
residu
morbid
mutat
indic
human
isoform
shown
known
pathogen
mutat
code
exon
number
roman
numer
delimit
vertic
bar
region
correspond
coiledcoil
domain
cc
dnabind
domain
dnab
linker
domain
l
domain
tail
segment
domain
ts
transactiv
domain
ta
indic
togeth
aminoacid
boundari
delimit
bold
line
py
ps
indic
mutat
green
domin
associ
partial
defici
msmd
mutat
brown
recess
associ
complet
defici
intracellular
viral
diseas
mutat
blue
recess
associ
partial
defici
mild
intracellular
andor
viral
diseas
mutat
red
domin
associ
gainofact
cmcd
cc
consider
potenti
involv
proteinprotein
interact
play
key
role
dimer
unphosphoryl
nuclear
dephosphoryl
dnabind
domain
dnab
includ
residu
asn
ly
come
contact
dna
major
groov
glu
come
contact
minor
groov
addit
residu
contribut
nuclear
import
phosphoryl
dimer
bind
wherea
other
involv
nuclear
export
protein
linker
domain
l
involv
ifngdriven
transcript
stabil
dna
bind
domain
play
essenti
role
bind
phosphoryl
surfac
receptor
phosphoryl
tail
stat
tail
segment
ts
includ
crucial
tyr
residu
phosphoryl
jak
upon
activ
therebi
facilit
dimer
interact
domain
anoth
stat
transactiv
domain
ta
enabl
protein
induc
modul
transcript
target
gene
also
contain
ser
residu
phosphoryl
increas
transcript
activ
structurefunct
relationship
variou
domain
residu
character
detail
immunolog
infecti
phenotyp
mice
knockout
mice
gener
two
differ
group
despit
demonstr
activ
divers
cytokin
hormon
vitro
knockout
mice
born
mendelian
proport
display
overt
development
abnorm
leukocyt
count
low
popul
cell
test
cell
b
cell
monocyt
macrophag
granulocyt
except
regulatori
cell
howev
mice
respond
poorli
ifnab
ifng
demonstr
absenc
detect
gamma
activ
factor
gaf
homodim
interferonstimul
gene
factor
heterotrim
transcript
gene
usual
induc
ifnab
ifng
abolish
highlight
nonredund
role
two
correspond
pathway
interestingli
residu
respons
subsequ
report
also
shown
nonredund
cellular
respons
ifnl
respect
overal
correct
cellular
respons
least
four
cytokin
mous
model
seem
highli
depend
mous
appear
redund
respons
least
cytokin
host
pathogen
tabl
infecti
phenotyp
knockout
mice
tabl
unsurprisingli
mice
highli
suscept
virus
includ
singlestrand
rna
virus
sindbi
chikungunya
viru
chikv
mous
hepat
viru
mhv
sever
acut
respiratori
syndrom
coronaviru
sarscov
murin
noroviru
singlestrand
rna
virus
vesicular
stomat
viru
vsv
influenza
viru
filovirus
ebola
marburg
reston
ebola
machupo
viru
macv
crimeancongo
hemorrhag
fever
viru
cchfv
sendai
viru
sev
doublestrand
dna
virus
herp
simplex
viru
hsv
mous
cytomegaloviru
mcmv
howev
seem
normal
resist
singlestrand
rna
dengu
viru
singlestrand
rna
measl
virus
knockout
mice
less
suscept
infect
mcmv
sindbi
virus
mice
doubl
knockout
ifngr
ifnabr
presum
owe
respons
knockout
mice
also
suscept
infect
intracellular
gramposit
bacteria
listeria
monocytogen
mycobacterium
tuberculosi
intracellular
gramneg
bacteria
francisella
novicida
chlamydia
pneumonia
larg
extracellular
borrelia
burgdorferi
mice
highli
suscept
parasit
toxoplasma
gondii
cryptosporidium
parvum
leishmania
major
normal
resist
infect
leishmania
donovani
bacteria
parasit
infect
macrophag
suscept
mice
probabl
close
resembl
ifngrdefici
mice
mice
also
challeng
fungu
candida
albican
respons
challeng
similar
wildtyp
mice
knowledg
mice
heterozyg
null
allel
test
transgen
mice
overexpress
wildtyp
mice
carri
hypomorph
hypermorph
allel
appear
describ
either
new
syndrom
character
associ
infecti
diseas
caus
intracellular
bacteria
typic
mycobacteria
virus
typic
herp
virus
clinic
describ
genet
elucid
infect
resembl
seen
patient
tcell
combin
immunodefici
except
patient
normal
tlymphocyt
count
function
known
patient
carri
biallel
lossofexpress
lossoffunct
lof
allel
lead
complet
absenc
wildtyp
protein
missens
mutat
lead
infram
splice
code
exon
small
frameshift
delet
small
frameshift
insert
six
patient
four
unrel
famili
identifi
date
tabl
figur
unpublish
data
pure
recess
disord
haploinsuffici
locu
report
known
cellular
clinic
phenotyp
patient
suscept
weakli
virul
mycobacteria
bcg
vaccin
mycobacterium
kansasii
herp
virus
cmv
control
attenu
polioviru
type
iii
vaccin
rhinoviru
parainfluenza
viru
type
ii
inborn
error
human
immun
boissondupui
et
al
tabl
four
type
inborn
error
human
immun
one
patient
suggest
innat
antivir
mechan
may
suffici
human
nevertheless
five
patient
die
two
month
age
mycobacteri
diseas
two
month
age
viral
diseas
includ
one
enceph
hse
anoth
month
age
sever
hepat
cours
hematopoiet
stem
cell
transplant
hsct
sixth
patient
still
aliv
one
year
hsct
key
infecti
phenotyp
patient
seen
patient
inborn
error
cytokin
immun
induct
ifnab
ifnl
shown
impair
children
hse
moreov
mycobacteri
diseas
children
shown
result
impair
ifngmedi
immun
ifngr
defici
also
lifethreaten
disord
ebvtransform
b
cell
ebvb
cell
fibroblast
patient
unrespons
ifng
ifna
term
gaf
activ
also
unrespons
ifnl
stimul
term
gafdna
bind
activ
induct
target
gene
respect
ebvb
cell
fibroblast
patient
complet
defici
control
replic
virus
vsv
emcv
even
treatment
ifna
addit
induct
mxa
influenza
infect
shown
requir
ifnabdepend
ifnl
signal
moreov
leukocyt
patient
impair
respons
ifng
term
induct
target
gene
induct
ifng
document
ifnastimul
nk
cell
patient
addit
shown
dispens
follicular
helper
tfh
cell
differenti
memori
bcell
format
ig
secret
patient
cell
vitro
overal
suscept
patient
mycobacteria
intracellular
bacteria
may
larg
explain
impair
ifnggaf
host
pathogen
schemat
diagram
role
antivir
antimycobacteri
immun
schemat
represent
signal
pathway
respons
ifng
ifnab
ifnl
human
depend
ifng
immun
crucial
protect
mycobacteria
intramacrophag
microb
role
immun
process
exclud
depend
ifnab
immun
crucial
protect
virus
mainli
herp
virus
role
ifnl
immun
exclud
immun
inde
ifng
alreadi
shown
essenti
human
antimycobacteri
immun
figur
see
role
impair
immun
although
unlik
possibl
least
consid
ifnginduc
cytokin
decreas
ifng
respons
contrast
observ
suscept
virus
larg
owe
impair
ifnab
respons
infer
suscept
ifnabrdefici
mice
figur
contribut
impair
ifnl
immun
plausibl
least
viral
infect
infer
mous
model
role
human
ifnl
clearanc
hepat
c
viru
patient
lack
one
two
chain
receptor
ifnl
report
particularli
suscept
viral
diseas
howev
rare
patient
die
underw
hsct
earli
life
possibl
prevent
express
viral
phenotyp
case
cellular
clinic
penetr
complet
defici
appear
complet
homozyg
patient
equal
sever
cellular
clinic
phenotyp
hsct
appear
cur
treatment
patient
identif
investig
larger
number
patient
requir
improv
delin
redund
nonredund
role
human
cell
signal
host
defens
beyond
ar
partial
defici
milder
intramacrophag
bacteri
viral
diseas
onward
five
patient
three
unrel
kindr
identifi
partial
oppos
complet
form
ar
defici
tabl
figur
patient
harbor
biallel
mutat
homozyg
two
kindr
compound
heterozyg
third
hypomorph
oppos
amorph
four
mutat
missens
reduc
abolish
product
one
mutat
affect
ntd
two
affect
ccd
one
affect
tsd
precis
function
data
avail
mutat
three
mutat
unusu
missens
mutat
also
primarili
splice
mutat
inde
two
mutat
ccd
region
caus
splicingout
exon
wherea
tsd
region
splice
exon
mutat
effect
function
residu
fulllength
produc
account
partial
natur
defect
mutat
character
respect
comparison
complet
defici
disord
thu
associ
milder
intramacrophag
bacteri
salmonella
avium
bcg
viral
cmv
vzv
rsv
diseas
cure
antibacteri
antivir
drug
four
five
patient
aliv
age
year
last
followup
fifth
patient
die
sepsi
age
three
year
episod
dissemin
mycobacteri
diseas
two
patient
seroposit
ebv
cmv
anoth
seroposit
ebv
cmv
vzv
patient
abl
mount
effect
immun
respons
least
virus
lead
control
teen
probabl
expos
control
virus
well
unlik
ebvb
cell
patient
complet
defici
cell
patient
partial
defici
produc
residu
nonnul
amount
function
correspond
normal
level
depend
mutat
consequ
cell
impair
abolish
respons
ifng
ifna
treatment
term
gaf
activ
also
display
impair
respons
stimul
ifnl
abil
patient
cell
control
viral
infect
vsv
hsv
vitro
treatment
ifna
seem
depend
mutat
possibl
level
residu
activ
ifna
stimul
case
impair
abolish
ifnab
andor
ifnl
respons
probabl
account
viral
infect
phenotyp
less
sever
patient
complet
defici
figur
small
number
patient
partial
defici
identifi
may
signific
none
hse
similarli
residu
respons
ifng
perhap
may
well
account
mycobacteri
infect
curabl
thorough
investig
cellular
phenotyp
confer
one
mutat
suggest
express
gene
induc
ifng
earli
respons
phase
particularli
impair
least
fibroblast
identifi
group
gene
import
antimycobacteri
immun
overal
defect
partial
patient
display
less
sever
clinic
diseas
patient
complet
defect
howev
degre
sever
diseas
shown
vari
patient
even
within
given
famili
amount
function
residu
produc
may
differ
sibl
mutat
splice
mutat
nevertheless
clinic
penetr
partial
defici
also
appear
complet
overal
level
product
activ
correl
sever
bacteri
viral
infect
patient
ar
defici
clearli
two
differ
form
ar
defici
studi
natur
histori
provid
differ
complementari
inform
role
host
defens
mendelian
suscept
mycobacteri
diseas
msmd
rare
syndrom
character
infect
schemat
diagram
role
antimycobacteri
antivir
antifung
immun
three
panel
protein
mutat
correspond
gene
identifi
associ
msmd
hse
cmc
respect
shown
blue
shown
red
top
panel
weakli
pathogen
mycobacteria
bcg
vaccin
environment
mycobacteria
otherwis
healthi
individu
patient
also
suscept
virul
mycobacterium
tuberculosi
half
also
suffer
nontyphoid
salmonellosi
sinc
discoveri
first
genet
etiolog
eight
morbid
gene
nemo
cybb
found
figur
collect
defin
genet
disord
affect
ifngmedi
immun
context
first
human
patient
form
inherit
defici
discov
identif
two
patient
unrel
kindr
heterozyg
lof
dominantneg
allel
two
patient
suffer
rel
mild
msmd
dissemin
bcg
diseas
avium
curabl
without
recurr
two
inborn
error
human
immun
boissondupui
et
al
figur
legend
continu
phagocytosi
mycobacteria
lead
cytokin
product
cooper
phagocytesdendrit
cell
nkt
cell
loop
pathway
oxid
burst
mediat
cybb
compon
nadph
oxidas
crucial
protect
immun
mycobacteria
human
defici
associ
impair
ifng
respons
middl
panel
recognit
dsrna
induc
activ
nfkb
pathway
via
trif
lead
ifnab
andor
ifnl
product
trif
nemo
defici
associ
impair
ifnab
andor
ifnl
product
particularli
herp
viru
infect
bind
ifnab
ifnl
receptor
induc
phosphoryl
activ
signal
transduct
protein
complex
transloc
heterotrim
nucleu
act
transcript
activ
bind
specif
dna
respons
element
promot
region
ifninduc
gene
defici
associ
impair
ifna
ifnb
ifnl
respons
bottom
panel
follow
recognit
c
albican
adaptor
molecul
mediat
induct
proinflammatori
cytokin
product
myeloid
epitheli
cell
proinflammatori
cytokin
includ
activ
lymphocyt
via
induc
differenti
cell
cell
cell
constitut
major
compon
immun
defens
c
albican
gainoffunct
mutat
inhibit
differenti
respons
ifnab
ifng
ifnl
impair
normal
andor
signal
yet
undetermin
mechan
clinic
consequ
low
high
level
activ
narrow
rang
activ
maintain
ensur
health
biallel
even
monoallel
lossoffunct
lof
allel
includ
null
also
hypomorph
allel
confer
predisposit
mycobacteri
diseas
owe
impair
ifng
immun
concomit
impair
ifnab
ifnl
signal
predispos
patient
viral
ill
sever
clinic
phenotyp
depend
sever
cellular
phenotyp
impact
hyporespons
unclear
contrast
heterozygos
gainoffunct
gof
allel
owe
gain
phosphoryl
loss
nuclear
dephosphoryl
predispos
patient
chronic
mucocutan
candidiasi
cmc
autoimmun
typic
thyroid
rare
condit
system
lupu
erythematosu
mechan
underli
cmc
involv
impair
develop
cell
owe
enhanc
respons
inhibitor
ifng
ifnab
ifnl
weak
respons
owe
enhanc
respons
induc
mechan
underli
autoimmun
probabl
involv
enhanc
ifnab
respons
children
first
patient
also
heterozyg
absenc
bcg
vaccin
remain
healthi
none
four
patient
identifi
ever
display
unusu
sever
viral
ill
least
recent
checkup
visit
age
year
unpublish
data
sinc
six
kindr
found
carri
dominantneg
mutat
associ
msmd
figur
mutat
missens
two
mutat
affect
dnab
three
other
fifth
mutat
affect
tyr
hirata
et
al
prepar
patient
eight
kindr
suffer
msmd
bcgosi
avium
diseas
one
patient
suffer
bona
fide
tuberculosi
caus
tuberculosi
sever
mutat
clinic
penetr
incomplet
five
genet
affect
rel
index
case
two
known
vaccin
bcg
remain
clinic
healthi
transfect
fibrosarcoma
cell
lack
owe
somat
event
msmdcaus
allel
shown
allel
lof
broad
sens
includ
amorph
hypomorph
allel
owe
lossofphosphoryl
ifnggaf
ifnaisr
signal
pathway
other
found
deleteri
owe
impair
dnabind
one
mutat
affect
tyr
phosphoryl
dnabind
activ
howev
cell
heterozyg
patient
mutant
allel
shown
domin
ifnggaf
activ
recess
ifnaisr
activ
word
respons
ifng
impair
heterozyg
cell
wherea
respons
ifnab
unaffect
provid
first
exampl
human
allel
intrins
null
two
cellular
phenotyp
recess
one
domin
heterozyg
cell
also
know
dichotomi
appli
level
whole
organ
patient
ad
defici
msmd
wherea
ar
defici
suscept
mycobacteri
viral
diseas
mechan
domin
recess
gaf
activ
respect
deciph
haploinsuffici
assess
gaf
dnabind
activ
cell
heterozyg
lossofexpress
allel
mutant
protein
also
intrins
abl
associ
phosphoryl
form
dimer
mutant
wt
lack
phosphoryl
mutant
protein
inabl
bind
dna
therefor
destroy
activ
dimer
contain
result
dimer
combin
two
phosphoryl
wildtyp
molecul
function
account
detect
normal
level
gaf
activ
null
allel
respons
ifng
patient
cell
convers
mutat
molecul
like
bind
phosphoryl
recruit
activ
ifnab
receptor
complex
wt
molecul
therefor
recruit
heterozyg
cell
mutat
molecul
dnab
bind
phosphoryl
impair
bind
dna
target
result
normal
respons
ifna
format
albeit
suffici
quantiti
haploinsuffici
locu
abil
patient
cell
respond
correctli
ifnab
control
viral
infect
vitro
account
lack
clinic
phenotyp
vivo
patient
cell
also
respond
well
ifnl
term
mrna
induct
discuss
poor
cellular
respons
ifng
account
patient
suscept
mycobacteria
figur
recipi
cell
transfect
mutant
allel
null
gaf
activ
respons
moreov
patient
cell
also
respond
poorli
potenti
contribut
clinic
phenotyp
given
implic
ifngdepend
antibacteri
immun
mous
identif
patient
carri
mutat
gene
encod
receptor
would
facilit
assess
contribut
molecul
antimycobacteri
immun
event
dominantneg
allel
identifi
confer
predisposit
viral
diseas
may
underli
ad
msmd
rare
patient
although
null
sever
hypomorph
signal
pathway
allel
impair
ifng
respons
ifnab
respons
heterozyg
cell
heterozyg
gainoffunct
allel
discov
patient
chronic
mucocutan
candidiasi
cmc
candida
albican
fungu
caus
invas
chronic
mucocutan
diseas
immunocompromis
patient
cmc
common
patient
clinic
sign
carri
variou
inborn
error
immun
includ
mutat
air
defect
associ
impair
immun
whether
owe
impair
develop
cell
mutat
lesser
extent
high
titer
neutral
autoab
cytokin
air
suggest
andor
play
import
role
mucocutan
immun
c
albican
figur
consist
hypothesi
genet
predisposit
cmc
diseas
cmcd
rare
patient
without
clinic
featur
associ
aforement
defect
attribut
specif
hypomorph
heterozyg
mutat
kindr
ad
cmcd
biallel
amorph
mutat
kindr
ar
cmcd
surprisingli
heterozyg
mutat
discov
context
wholeexom
sequenc
genomewid
linkag
analysi
patient
cmcd
includ
patient
autoimmun
sign
figur
first
report
describ
mutat
patient
kindr
anoth
report
identifi
two
mutat
patient
five
famili
third
report
subsequ
identifi
two
famili
seven
patient
cmcd
carri
known
mutat
altogeth
patient
cmcd
kindr
report
heterozyg
mutant
allel
tabl
remark
mutat
affect
ccd
moreov
missens
mutat
includ
six
found
sever
unrel
kindr
appear
due
mutat
hotspot
rather
founder
effect
mutat
segreg
clinic
phenotyp
clinic
penetr
appear
complet
although
clinic
sever
vari
even
within
famili
addit
recent
identifi
new
cmcd
patient
famili
heterozyg
mutat
affect
dnab
ccd
respect
okada
et
al
prepar
heterozyg
mutat
account
approxim
half
patient
enrol
cmc
cohort
cmcdcaus
mutant
allel
shown
gainoffunct
gof
cellular
level
gain
function
result
gain
phosphoryl
follow
transfect
fibrosarcoma
cell
allel
respons
ifng
ifna
reproduc
two
three
time
stronger
control
cell
term
phosphoryl
gasbind
activ
report
gene
induct
induct
endogen
target
gene
mechan
underli
gof
analyz
inhibitor
kinas
phosphatas
shown
larg
exclus
associ
impair
nuclear
dephosphoryl
okada
et
al
prepar
sever
residu
close
affect
cmcdcaus
mutat
ccd
dnab
shown
sitedirect
mutagenesi
essenti
dephosphoryl
heterozyg
cell
patient
also
display
stronger
respons
ifng
ifna
demonstr
gof
allel
domin
cellular
level
cell
also
display
defect
nuclear
dephosphoryl
heterozygos
gof
allel
therefor
account
ad
cmcd
autoimmun
autoimmun
seen
patient
probabl
reflect
enhanc
cellular
respons
ifnab
immunolog
mechan
underli
cmc
analysi
cell
ex
vivo
vitro
highlight
profound
defect
develop
cell
patient
observ
provid
cellular
basi
cmc
patient
heterozyg
gof
allel
also
rais
question
underli
mechan
possibl
excess
respons
one
sever
cytokin
known
inhibit
tcell
develop
ifng
ifna
figur
whether
lead
decreas
increas
transcript
key
target
gene
respect
control
impair
develop
cell
patient
render
suscept
cmc
altern
enhanc
activ
may
divert
respons
normal
preferenti
use
signal
favor
develop
cell
figur
two
hypothes
mutual
exclus
mechan
may
also
oper
work
requir
investig
mechan
heterozyg
gof
allel
impair
tcell
develop
molecular
cellular
level
howev
recent
studi
clearli
establish
cmc
develop
patient
heterozyg
gof
allel
impair
develop
cell
knowledg
first
human
gene
identifi
lof
gof
heterozyg
allel
appar
associ
rel
narrow
set
distinct
infecti
diseas
heterozygot
lof
dominantneg
allel
display
msmd
wherea
heterozygot
gof
domin
allel
display
cmcd
mutat
may
even
affect
domain
first
host
defens
gene
harbor
lof
gof
mutat
differ
patient
situat
alreadi
demonstr
xlink
wasp
gene
lof
mutat
underli
xr
wiskottaldrich
syndrom
wherea
gof
mutat
underli
xr
sever
congenit
neutropenia
rang
infect
seen
two
xlink
trait
howev
broader
overlap
moreov
two
four
distinct
disord
appar
associ
specif
set
infecti
diseas
heterozyg
morbid
allel
associ
ad
msmd
ad
cmcd
wherea
biallel
lof
mutat
whether
amorph
hypomorph
associ
ar
predisposit
mycobacteri
viral
diseas
intriguingli
howev
two
patient
heterozyg
gof
allel
recent
shown
display
recurr
herp
viru
infect
reminisc
patient
might
involv
mechan
impair
cell
memori
final
sever
infecti
phenotyp
pronounc
patient
ar
complet
defici
patient
partial
form
defici
set
bacteri
viral
diseas
may
broader
patient
complet
defici
although
better
prognosi
patient
partial
defect
may
reveal
infect
seen
complet
defici
die
earli
childhood
unless
treat
hsct
discoveri
character
variou
human
morbid
allel
built
eleg
studi
human
mous
cell
line
vitro
mous
model
vivo
human
studi
help
elucid
function
host
defens
natura
context
natur
ecosystem
govern
natur
select
rang
natur
viral
infect
control
ifnabdepend
ifnldepend
immun
gradual
deciph
clearli
human
ifng
immun
crucial
protect
mycobacteria
rel
limit
set
intramacrophag
microb
surprisingli
gain
activ
impair
develop
cell
impair
mucocutan
immun
c
albican
littl
immun
whether
owe
monoallel
dominantneg
biallel
lof
mutat
associ
predisposit
viral
andor
mycobacteri
diseas
convers
much
immun
owe
monoallel
gof
mutat
associ
cmc
autoimmun
figur
therefor
probabl
strong
evolutionari
pressur
favor
mainten
optim
activ
even
heterozyg
mutat
increas
decreas
activ
protein
outsid
particular
rang
would
subject
strong
counterselect
evolut
popul
evolutionari
genet
studi
human
popul
would
probabl
reveal
strong
purifi
select
oper
locu
recent
shown
human
gene
encod
sever
ifn
includ
ifnab
ifng
